Chiral Recognition R- and RS- of New Antifungal: Complexation/Solubilization/Dissolution Thermodynamics and Permeability Assay
暂无分享,去创建一个
[1] T. Volkova,et al. Physicochemical profile of new antifungal compound: pH-dependent solubility, distribution, permeability and ionization assay , 2021 .
[2] T. Volkova,et al. Thiazolidine-2,4-dione derivative in 2-hydroxypropyl-β-cyclodextrin solutions: Complexation/solubilization, distribution and permeability , 2021, Journal of Molecular Liquids.
[3] T. Volkova,et al. Comparative analysis of solubilization and complexation characteristics for new antifungal compound with cyclodextrins. Impact of cyclodextrins on distribution process. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] T. Volkova,et al. New antifungal compound: Solubility thermodynamics and partitioning processes in biologically relevant solvents , 2020 .
[5] T. Manning,et al. Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis. , 2017, Tuberculosis.
[6] K. Yannakopoulou,et al. Molecular recognition of N-acetyltryptophan enantiomers by β-cyclodextrin , 2017, Beilstein journal of organic chemistry.
[7] Uttam Pal,et al. Evidence of two structurally related solvatochromic probes complexed with β-cyclodextrin by using spectroscopic methods , 2017 .
[8] W. Misiuk. Investigation of inclusion complex of HP-γ-cyclodextrin with ceftazidime , 2016 .
[9] A. Salgado,et al. Applications of nuclear magnetic resonance spectroscopy for the understanding of enantiomer separation mechanisms in capillary electrophoresis. , 2016, Journal of chromatography. A.
[10] E. Pavlidou,et al. Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes , 2016, International journal of molecular sciences.
[11] A. Bauer-Brandl,et al. New biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] F. Otero-Espinar,et al. Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery , 2014, Beilstein journal of organic chemistry.
[13] Liang Zhao,et al. Enantioseparation of new triadimenol antifungal active compounds by electrokinetic chromatography and molecular modeling study of chiral recognition mechanisms , 2014, Electrophoresis.
[14] M. Trojanowicz. Enantioselective electrochemical sensors and biosensors: A mini-review , 2014 .
[15] S. Nair,et al. Solubility enhancement methods -a promising technology for poorly water soluble drugs , 2013 .
[16] Bing Zhao,et al. Structural Studies for Specific Binding Capacity of β‐Cyclodextrin with Ibuprofen , 2012 .
[17] A. Dahan,et al. Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation. , 2012, International journal of pharmaceutics.
[18] Lu Wang,et al. Determination of the enantioselectivity of six chiral aryloxy aminopropanol drugs transport across Caco-2 cell monolayers , 2012 .
[19] U. Domańska,et al. Effect of 2-Hydroxypropyl-β-cyclodextrin on Solubility of Sparingly Soluble Drug Derivatives of Anthranilic Acid , 2011, International journal of molecular sciences.
[20] L. Belyakova,et al. Thermodynamic, IR spectral and X-ray diffraction studies of the “β-cyclodextrin-para-aminobenzoic acid” inclusion complex , 2011 .
[21] Suzanne Skolnik,et al. Attenuation of Intestinal Absorption by Major Efflux Transporters: Quantitative Tools and Strategies Using a Caco-2 Model , 2011, Drug Metabolism and Disposition.
[22] A. Badwan,et al. The role of drug hydrophobicity in β-cyclodextrin complexes , 2010 .
[23] Umari,et al. Photophysical Behaviour of p-Dihydroxy Benzene in Different Solvents , pH and α-Cyclodextrin , 2010 .
[24] Thorsteinn Loftsson,et al. Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.
[25] Thorsteinn Loftsson,et al. The complexation efficiency , 2007 .
[26] Wolfgang Lindner,et al. Chirality in drug research , 2006 .
[27] Thorsteinn Loftsson,et al. Evaluation of cyclodextrin solubilization of drugs. , 2005, International journal of pharmaceutics.
[28] D. Paolino,et al. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study. , 2005, European journal of medicinal chemistry.
[29] J. Nerurkar,et al. Solubility of ( ± )-Ibuprofen and S ( + )-Ibuprofen in the Presence of Cosolvents and Cyclodextrins , 2005, Pharmaceutical development and technology.
[30] A. Avdeef,et al. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] E. D. Valle,et al. Cyclodextrins and their uses: a review , 2004 .
[32] M. Brewster,et al. Self-association of cyclodextrins and cyclodextrin complexes. , 2004, Journal of pharmaceutical sciences.
[33] R. Stancanelli,et al. Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin. , 2004, Journal of pharmaceutical and biomedical analysis.
[34] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[35] Valentino J. Stella,et al. The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins , 1996, Pharmaceutical Research.
[36] Y. Yoshihashi,et al. Quantitative Relationship Between Solubility, Initial Dissolution Rate and Heat of Solution of Chiral Drugs , 2004, Pharmaceutical Research.
[37] D. Loebenberg,et al. Relationship Among Physicochemical Properties, Skin Permeability, and Topical Activity of the Racemic Compound and Pure Enantiomers of a New Antifungal , 2004, Pharmaceutical Research.
[38] M. Brewster,et al. Alfaxalone: Effect of Temperature on Complexation with 2-Hydroxypropyl-β-cyclodextrin , 2002 .
[39] Yoshihisa Inoue,et al. Complexation and chiral recognition thermodynamics of 6-amino-6-deoxy-beta-cyclodextrin with anionic, cationic, and neutral chiral guests: counterbalance between van der Waals and coulombic interactions. , 2002, Journal of the American Chemical Society.
[40] V. Schurig. Separation of enantiomers by gas chromatography. , 2001, Journal of chromatography. A.
[41] W. Lindner,et al. Separation of enantiomers: needs, challenges, perspectives. , 2001, Journal of chromatography. A.
[42] Yoshihisa Inoue,et al. Chiral Recognition Thermodynamics of β-Cyclodextrin: The Thermodynamic Origin of Enantioselectivity and the Enthalpy−Entropy Compensation Effect , 2000 .
[43] W. Curatolo,et al. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings , 1998 .
[44] Y. Inoue,et al. Complexation Thermodynamics of Cyclodextrins. , 1998, Chemical reviews.
[45] H. Leuenberger,et al. Solubility properties of racemic praziquantel and its enantiomers. , 1998, Pharmaceutical development and technology.
[46] A. Burger,et al. RS-ibuprofen and S-ibuprofen (dexibuprofen) : Binary system and unusual solubility behaviour , 1996 .
[47] D. Chatterjee,et al. Permeability of pure enantiomers of ketorolac through human cadaver skin. , 1995, Journal of pharmaceutical sciences.
[48] K. Lipkowitz,et al. Enantioselective binding of tryptophan by .alpha.-cyclodextrin , 1992 .
[49] G. Tucker,et al. Enantiomer specific pharmacokinetics. , 1990, Pharmacology & therapeutics.
[50] Makoto Komiyama,et al. Importance of apolar binding in complex formation of cyclodextrins with adamantanecarboxylate , 1978 .
[51] Takuji Sugimoto,et al. Approach to the aspects of driving force of inclusion by .alpha.-cyclodextrin , 1978 .
[52] V. Dl,et al. Cycloamyloses as enzyme models. Effects of inclusion complex formation on intramolecular participation. , 1970 .
[53] M. L. Bender,et al. Cycloamyloses as enzyme models. Effects of inclusion complex formation on intramolecular participation. , 1970, Journal of the American Chemical Society.
[54] T. Higuchi,et al. Phase solubility techniques , 1965 .
[55] P. Molyneux,et al. The Interaction of Polyvinylpyrrolidone with Aromatic Compounds in Aqueous Solution. Part I. Thermodynamics of the Binding Equilibria and Interaction Forces1 , 1961 .
[56] E. Rosenbaum,et al. Ultraviolet Spectra of Aromatic Compounds , 1952 .